OPTI expands clinic network and plans U.S. entry pending approval
The company says it is growing its clinic network and preparing for U.S. entry, while it is commercial with psilocybin and MDMA products in Australia and Canada.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.